Up-regulation of 'clearance' receptors in patients with chronic heart failure: A possible explanation for the resistance to biological effects of cardiac natriuretic hormones

European Journal of Heart Failure

Volumn 3, Issue 4, 2001, Pages 407-414

  Andreassi, M G ^a   Del Ry, S ^a   Palmieri, C ^a   Clerico, A ^a   Biagini, A ^a   Giannessi, D ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

ANP; BNP; Clearance receptor; Heart failure; Natriuretic peptides; Platelets

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; HORMONE RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HORMONE RESISTANCE; HUMAN; LIGAND BINDING; MALE; METABOLIC CLEARANCE RATE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR UPREGULATION; THROMBOCYTE;

ADULT; AGED; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHRONIC DISEASE; CYCLIC GMP; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 0034891640     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00161-1     Document Type: Article

References (42)

1. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomiopathy and its relationship with clinical severity of the disease and sodium handling
2. Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: How do they relate to the resistance to atrial natriuretic peptides?
3. Atrial natriuretic peptide elevation in congestive heart failure in the human
4. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
5. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-side heart failure
6. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the Registry of Studies of Left Ventricular Dysfunction
7. Atrial natriuretic peptide in heart failure
8. Measurement and significance of circulating natriuretic peptides in cardiovascular diseases
9. Immunoassay methods for the measurement of natriuretic cardiac hormones - ANP, BNP, and related peptides - In humans
10. Neurohormonal mechanisms in congestive heart failure
11. Atrial natriuretic factor in normal subjects and heart failure patients
12. Effects of atrial natriuretic factors in rats with experimental high-output failure
13. Atrial natriuretic factor receptors and signal transduction mechanisms
14. Natriuretic peptide C-receptor: More than a clearance receptor
15. Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure
16. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
17. Preparation of monoradio-iodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans
18. Role of the renal sympathetic nerves in mediating hypoperfusion of renal microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion
19. Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure
20. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure
21. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure
22. Binding sites for atrial natriuretic peptide on platelets in patients with congestive cardiomyopathy
23. Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: Correlation with peptide biological effects
24. Trasient downregulation of glomerular atrial natriuretic factor receptors in high output heart failure in the rat
25. Alteration of lung atrial natriuretic peptide receptors in genetic cardiomyopathy
26. Clearance function of type C receptors of atrial natriuretic factor in rats
27. Influence of A-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats
28. Physiological role of silent receptors of atrial natriuretic factor
29. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat and human
30. Expression and regulation of ANF receptor subtypes in rat renal glomeruli and papillae
31. Identification of the receptor for atrial natriuretic factor on cultured vascular cells
32. Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP
33. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells
34. Inhibition of endothelial cells clearance of atrial natriuretic peptide by cyclic GMP treatment
35. Biological role of atrial natriuretic factor clearance receptor in congestive heart failure
36. Natriuretic peptide receptor expression in human failings hearts
37. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: Evidence from a population-based study
38. Effect of the beta 1-blocker/beta 2-agonist celiprolol on atrial natriuretic peptide plasma levels in hypertensive patients
39. Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides
40. Atrial natriuretic peptide: Synthesis, release, and metabolism
41. Cardiorenal actions of neutral peptidase inhibition in experimental congestive heart failure
42. Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure